Keratosis pilaris-like eruption observed during the experimental PLX 4032 studies. 2012

Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007642 Keratosis Any horny growth such as a wart or callus. Keratoderma Blennorrhagicum,Keratoma,Keratosis Blennorrhagica,Blennorrhagica, Keratosis,Blennorrhagicas, Keratosis,Blennorrhagicum, Keratoderma,Blennorrhagicums, Keratoderma,Keratoderma Blennorrhagicums,Keratomas,Keratoses,Keratosis Blennorrhagicas
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077484 Vemurafenib An indole sulfonamide compound and inhibitor of BRAF KINASES that is used for the treatment of unresectable or metastatic MELANOMA. PLX 4032,PLX4032,R05185426,RG-7204,RG7204,Zelboraf,RG 7204
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D017322 Clinical Trials, Phase II as Topic Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries. Drug Evaluation, FDA Phase 2 as Topic,Drug Evaluation, FDA Phase II as Topic,Evaluation Studies, FDA Phase 2 as Topic,Evaluation Studies, FDA Phase II as Topic

Related Publications

Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
December 2021, Italian journal of dermatology and venereology,
Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
April 2012, Dermatology online journal,
Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
April 2019, JAAD case reports,
Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
September 2020, Pediatric dermatology,
Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
August 2013, Journal of the American Academy of Dermatology,
Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
June 2014, Journal of cutaneous pathology,
Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
April 2006, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
February 1978, American family physician,
Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
January 1954, Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
Kaisa van der Kooi, and L Frank Glass, and Jane L Messina, and James S Trimble
April 1999, Cutis,
Copied contents to your clipboard!